魏文秀, 荆兰兰, 刘新泳, 展鹏. 抗疱疹病毒药物化学研究新进展J. 药学学报, 2020,55(4): 575-584. doi: 10.16438/j.0513-4870.2019-0723
引用本文: 魏文秀, 荆兰兰, 刘新泳, 展鹏. 抗疱疹病毒药物化学研究新进展J. 药学学报, 2020,55(4): 575-584. doi: 10.16438/j.0513-4870.2019-0723
WEI Wen-xiu, JING Lan-lan, LIU Xin-yong, ZHAN Peng. New progress in medicinal chemistry of anti-herpesviruses drug researchJ. Acta Pharmaceutica Sinica, 2020,55(4): 575-584. doi: 10.16438/j.0513-4870.2019-0723
Citation: WEI Wen-xiu, JING Lan-lan, LIU Xin-yong, ZHAN Peng. New progress in medicinal chemistry of anti-herpesviruses drug researchJ. Acta Pharmaceutica Sinica, 2020,55(4): 575-584. doi: 10.16438/j.0513-4870.2019-0723

抗疱疹病毒药物化学研究新进展

New progress in medicinal chemistry of anti-herpesviruses drug research

  • 摘要: 目前临床使用最广泛的抗疱疹病毒药物为阿昔洛韦(acyclovir,ACV)及其衍生物,但耐药性问题的出现迫使人们不断寻找新的抗疱疹病毒药物。随着疱疹病毒的生物学特征和致病机制的深入研究以及新药设计与筛选技术的快速发展,越来越多的抗疱疹病毒新靶标和新抑制剂被发现,这使疱疹感染疾病的治疗有了更多选择。本综述总结了近年来在抗疱疹病毒药物研究领域的代表性研究成果。

     

    Abstract: At present, the most widely used anti-herpesviruses drugs are acyclovir (ACV) and its derivatives, but the emergence of herpesvirus resistance to these drugs forces people to continue to seek new anti-herpesviruses drugs. More and more new targets and inhibitors against herpesviruses have been discovered, one reason is the in-depth study of the biological characteristics and pathogenic mechanism of herpesviruses, and the other is the rapid development of new drug design and screening technology. Therefore, there are more options for the treatment of herpes infections. This review summarizes the representative achievements in the field of anti-herpesviruses drugs in recent years.

     

/

返回文章
返回